We’re launching our IMPACTIVE webinar series to discuss mechanochemistry, green pharmaceuticals, and green chemistry. Save the date: our first session will take place on 28 May at 12:00 pm (noon) CEST, with a presentation by Evelina Colacino, our project coordinator.
Emmanuel Mignot visited the Institut Charles Gerhardt Montpellier (ICGM) at the University of Montpellier, France, to discover more about IMPACTIVE. It was an exceptional opportunity to exchange ideas and strengthen relations with our Estonian partners.
This pioneering study, using a drum mill for the first time for co-crystal formation, opens new pathways for sustainable, large-scale pharmaceutical co-crystal production
The IMPACTIVE project is launching a spin-off company. We’re looking for a visionary CEO to lead the way and shape the future of sustainable API manufacturing.
Our researchers from Radboud University are at the core of IMPACTIVE. This team works on exploring new reactions to synthesise pharmacologically active compounds at a lab scale while avoiding the use of solvents.
We’re turning two years old, and we’re celebrating by publishing our latest Annual Report, which analyses our recent developments.
Our Belgian partners are experts in creating highly interesting enantiopure compounds through a chemical process known as deracemisation. If you want to know more details, keep reading.
After our second year of collaboration, the IMPACTIVE project partners have celebrated their second general assembly in Cagliari, hosted by the Italian partner CSGI. The discussions focused on setting our priorities for the next two years, as well as sharing the progress we have made over the past year.
Our project leader, the University of Montpellier, wears many hats. They ensure smooth collaboration among partners while leading the development of innovative mechanochemical methods at lab scale.
On 13 and 14 June, IMPACTIVE will attend the EuroScience Open Forum 2024, held in Poland, with an exciting session about green pharma.